On June 2, 2020 MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) reported that it will present at the following virtual conferences (Press release, MorphoSys, JUN 2, 2020, View Source [SID1234560756]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Healthcare Conference
Date: June 3, 2020, 9:30am EDT (3:30pm CEST, 2:30pm BST)
Presenter: Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys,
Dr. Julia Neugebauer, Director Corporate Communications & IR

Goldman Sachs 41st Annual Global Healthcare Conference
Date: June 10, 2020, 8:50am EDT (2:50pm CEST, 1:50pm BST)
Presenter: Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys,
Dr. Julia Neugebauer, Director Corporate Communications & IR

J.P. Morgan European Healthcare Conference
Date: June 18, 2020
Presenter: Jens Holstein, Chief Financial Officer of MorphoSys,
Dr. Julia Neugebauer, Director Corporate Communications & IR

JMP Hematology and Oncology Forum
Date: June 18, 2020
Presenter: Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys,
Dr. Julia Neugebauer, Director Corporate Communications & IR

PDF versions of the presentations will be provided at www.morphosys.com. Links to available webcasts will be filed under www.morphosys.com/conference-calls.